Stomach Cancer Market 2028 By Therapy, Healthcare Provider and Geography | The Insight Partners

report image

Stomach Cancer Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapy (Chemotherapy, Radiotherapy, Surgery, Targeted Therapy, Others); Healthcare Provider (Hospitals, Cancer Research Organizations, Cancer Treatment Centers) and Geography

Report Code: TIPRE00004053 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Stomach cancer is also known as gastric cancer, it is caused due to the abnormal and out of control growth of the malignant cells in the stomach. This can be caused by age and food, which can increase the risk of stomach cancer. Indigestion and stomach discomfort, as well as loss of appetite, heartburn, and weight loss, are all indications of stomach cancer. Various approches are used in the treatment of stomach cancers such as, chemotherapy, radiation therapy, immunotherapy etc.


The "Global Stomach Cancer Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the stomach cancer market with detailed market segmentation by therapy and healthcare provider. The report provides key statistics on the market status of the leading stomach cancer market players and offers key trends and opportunities in the market.


  •   Based on therapy the market is segmenetd as, chemotherapy, radiotherapy, surgery, targeted therapy and others.
  •   Based on healthcare provider the market is segmented as, hospitals, cancer research organizations and cancer treatment centers.



  •   Growing prevalences of stomach and gastrointestinal cancers along with presence of other co-morbidities are expected to boost market growth during the forecast period.
  •   Growth in diagnostic and screening procedures of cancers for better treatment outlook.
  •   Presence of strong pipeline of therapeutic agents is expected to spur the market growth during the forecast period.
  •   Extensive R&D activities to develop novel and targeted therapies for management of stomach cancers.


  •   However, high cost of treatment therapy along with lack of reimbursement policies are expected to restrain market growth.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The stomach cancer market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the stomach cancer market in these regions.

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. There is big shift in demand for stomach and gastrointestinal cancer drugs and therapeutics because of pandemic situation and lockdown scenes so that people cannot come out from their homes and can't take their cancer treatments which ultimately affecting the demand for stomach cancer drugs.


The report covers key developments in the stomach cancer market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from stomach cancer market are anticipated to lucrative growth opportunities in the future with the rising demand for stomach cancer in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the stomach cancer market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Lilly
  •   GlaxoSmithKline PLC
  •   F. Hoffmann-La Roche Ltd
  •   sanofi-aventis U.S. LLC
  •   Novartis AG
  •   Otsuka Holdings Co. Ltd
  •   Bristol-Myers Squibb Company.
  •   Pfizer,Inc
  •   Merck KGaA
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies

- Lilly
- GlaxoSmithKline PLC
- F. Hoffmann-La Roche Ltd
- sanofi-aventis U.S. LLC
- Novartis AG
- Otsuka Holdings Co. Ltd
- Bristol-Myers Squibb Company.
- Pfizer,Inc
- Merck KGaA
- Dr. Reddy's Laboratories Ltd
- Genentech, Inc
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount